Maxim Biomedical, Inc.

Rockville, MD

UEI
YV7LJS28ERK8
CAGE
4EJW3
Primary NAICS
325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Asian-Pacific American Owned
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
1500 E Gude Dr, Rockville, MD 20850, USA
Website
maximbio.com
Founded
2005
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Maxim Biomedical, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
This requirement is for a multiplex blind-spot LFI supply kit. Contract · N3239826P0015 Bureau of Medicine and Surgery $155,000
Over the counter (OTC) covid-19 tests Contract · 75A50223C00043 Office of the Assistant Secretary for Preparedness and Response $49,536,000
The purpose of this contract is to procure over the counter (OTC) covid-19 tests. Contract · 75A50223C00004 Office of the Assistant Secretary for Preparedness and Response $2,700,000
8 million OTC covid-19 test kits Contract · W58P0522C0013 ACC Aberdeen Proving Ground $54,640,000
Radx tech - maxim sars-COV-2 antigen rapid test Contract · 75N92020C00020 National Heart Lung and Blood Institute $5,253,450

About Maxim Biomedical, Inc.

Maxim Biomedical, Inc. is a medical device manufacturing company located in Rockville, Maryland that specializes in the development and marketing of in vitro diagnostic and point of care testing solutions. Their products are used in wellness, biosecurity, and infectious disease testing.

Through past prime federal contract awards, Maxim Biomedical has provided COVID-19 antigen test kits, COVID-19 lateral flow immunoassay test kits, SARS-COV-2 lateral flow immunoassay test kits, RADX TECH SARS-COV-2 antigen rapid tests, HIV-1 antigen tests, and HIV-1 western blot licensed test kits. Contracting agencies have included the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response, HHS National Institutes of Health, HHS Centers for Disease Control and Prevention, and Department of Defense entities such as the Army Acquisition Support Center Joint Program Executive Office for Chemical and Biological Defense. No set aside designations were indicated on the contract awards.

Maxim Biomedical has not received any prime federal grants but was a subrecipient on federal grants from the University of Massachusetts Medical School to conduct clinical studies on point of care COVID-19 testing devices, assess test sensitivity/specificity, device usability, and safety.

Maxim Biomedical holds a single award Indefinite Delivery Contract from the Department of the Army's Acquisition Support Center Joint Program Executive Office for Chemical and Biological Defense to provide SARS-COV-2 lateral flow immunoassay test kits to support COVID-19 testing efforts. The IDV has a potential value of $45.5 million through May 2021. A $171,000 firm fixed price delivery order was also awarded under the IDV for test kit delivery to occur through June 2021. The IDV and order aim to procure test kits for COVID-19 testing across the Department of Defense and military services.

SBA capabilities narrative

Maxim HIV-1 Urine EIA, Cambridge Biotech HIV-1 Serum/Plasma/Urine Western Blot, Oral Fluid HIV EIA/Rapid Test, cGMP Contract Manufacture: BLA/PMA/510(K), Assay Development, Validation, Immunoassay,RIBA, PCR, Multiplex PCR, IHC, Molecular Diagnostic, IVD.

Quick answers

What is Maxim Biomedical, Inc.'s UEI?

Maxim Biomedical, Inc.'s Unique Entity ID (UEI) in SAM.gov is YV7LJS28ERK8.

What is Maxim Biomedical, Inc.'s CAGE code?

Maxim Biomedical, Inc.'s CAGE code is 4EJW3.

What is Maxim Biomedical, Inc.'s primary NAICS code?

Maxim Biomedical, Inc.'s primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).

Where is Maxim Biomedical, Inc. located?

Maxim Biomedical, Inc.'s physical address in SAM.gov is 1500 E Gude Dr, Rockville, MD 20850, USA.

Is Maxim Biomedical, Inc. registered in SAM.gov?

Yes. Maxim Biomedical, Inc.'s SAM.gov registration is active through December 2, 2026.

What is Maxim Biomedical, Inc.'s most recent federal award?

Maxim Biomedical, Inc.'s most recent federal contract award is This requirement is for a multiplex blind-spot LFI supply kit (N3239826P0015), from Bureau of Medicine and Surgery, on May 19, 2026.

On GovTribe

See Maxim Biomedical, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors